116 related articles for article (PubMed ID: 38927935)
1. P18: Novel Anticancer Peptide from Induced Tumor-Suppressing Cells Targeting Breast Cancer and Bone Metastasis.
Cui C; Huo Q; Xiong X; Na S; Mitsuda M; Minami K; Li B; Yokota H
Cancers (Basel); 2024 Jun; 16(12):. PubMed ID: 38927935
[TBL] [Abstract][Full Text] [Related]
2. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells.
Cui C; Huo Q; Xiong X; Li K; Fishel ML; Li B; Yokota H
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896207
[TBL] [Abstract][Full Text] [Related]
3. Anticancer peptides from induced tumor-suppressing cells for inhibiting osteosarcoma cells.
Cui CP; Huo QJ; Xiong X; Li KX; Ma P; Qiang GF; Pandya PH; Saadatzadeh MR; Bijangi Vishehsaraei K; Kacena MA; Aryal UK; Pollok KE; Li BY; Yokota H
Am J Cancer Res; 2023; 13(9):4057-4072. PubMed ID: 37818062
[TBL] [Abstract][Full Text] [Related]
4. Indolo-pyrido-isoquinolin based alkaloid inhibits growth, invasion and migration of breast cancer cells via activation of p53-miR34a axis.
Avtanski DB; Nagalingam A; Tomaszewski JE; Risbood P; Difillippantonio MJ; Saxena NK; Malhotra SV; Sharma D
Mol Oncol; 2016 Aug; 10(7):1118-32. PubMed ID: 27259808
[TBL] [Abstract][Full Text] [Related]
5. Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling.
Sun X; Li K; Hase M; Zha R; Feng Y; Li BY; Yokota H
Theranostics; 2022; 12(2):929-943. PubMed ID: 34976221
[No Abstract] [Full Text] [Related]
6. Zhuidu Formula suppresses the migratory and invasive properties of triple-negative breast cancer cells via dual signaling pathways of RhoA/ROCK and CDC42/MRCK.
Wu Q; Ma X; Jin Z; Ni R; Pan Y; Yang G
J Ethnopharmacol; 2023 Oct; 315():116644. PubMed ID: 37196814
[TBL] [Abstract][Full Text] [Related]
7. Lanostane inhibits the proliferation and bone metastasis of human breast cancer cells via inhibition of Rho-associated kinase signaling.
Du Y; Yan W; Wang Z; Wang C; Huang M; Tao Z; Wu Z
J BUON; 2020; 25(3):1323-1329. PubMed ID: 32862572
[TBL] [Abstract][Full Text] [Related]
8. Counterintuitive production of tumor-suppressive secretomes from Oct4- and c-Myc-overexpressing tumor cells and MSCs.
Li K; Sun X; Zha R; Liu S; Feng Y; Sano T; Aryal UK; Sudo A; Li BY; Yokota H
Theranostics; 2022; 12(7):3084-3103. PubMed ID: 35547745
[No Abstract] [Full Text] [Related]
9. Cryoprotective isoliquiritigenin-zein phosphatidylcholine nanoparticles inhibits breast cancer-bone metastasis by targeting JAK-STAT signaling pathways.
Ganesan K; Xu C; Xie C; Sui Y; Zheng C; Gao F; Chen J
Chem Biol Interact; 2024 Jun; 396():111037. PubMed ID: 38719172
[TBL] [Abstract][Full Text] [Related]
10. Gold clusters prevent breast cancer bone metastasis by suppressing tumor-induced osteoclastogenesis.
Zhang Z; Yao Y; Yuan Q; Lu C; Zhang X; Yuan J; Hou K; Zhang C; Du Z; Gao X; Chen X
Theranostics; 2020; 10(9):4042-4055. PubMed ID: 32226538
[No Abstract] [Full Text] [Related]
11. Differential regulation of rho GTPases during lung adenocarcinoma migration and invasion reveals a novel role of the tumor suppressor StarD13 in invadopodia regulation.
Al Haddad M; El-Rif R; Hanna S; Jaafar L; Dennaoui R; Abdellatef S; Miskolci V; Cox D; Hodgson L; El-Sibai M
Cell Commun Signal; 2020 Sep; 18(1):144. PubMed ID: 32900380
[TBL] [Abstract][Full Text] [Related]
12. XIAOPI formula inhibits the pre-metastatic niche formation in breast cancer via suppressing TAMs/CXCL1 signaling.
Zheng Y; Wang N; Wang S; Yang B; Situ H; Zhong L; Lin Y; Wang Z
Cell Commun Signal; 2020 Mar; 18(1):48. PubMed ID: 32213179
[TBL] [Abstract][Full Text] [Related]
13. Delivery of doxorubicin loaded P18 conjugated-poly(2-ethyl-oxazoline)-DOPE nanoliposomes for targeted therapy of breast cancer.
Bolat ZB; Nezir AE; Devrim B; Zemheri E; Gulyuz S; Ozkose UU; Yilmaz O; Bozkir A; Telci D; Sahin F
Toxicol Appl Pharmacol; 2021 Oct; 428():115671. PubMed ID: 34391753
[TBL] [Abstract][Full Text] [Related]
14. Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
Wang C; Bai F; Zhang LH; Scott A; Li E; Pei XH
Breast Cancer Res; 2018 Jul; 20(1):74. PubMed ID: 29996906
[TBL] [Abstract][Full Text] [Related]
15. Design of a targeted dual drug delivery system for boosting the efficacy of photoimmunotherapy against melanoma proliferation and metastasis.
Chen Y; Xu S; Ren S; Zhang J; Xu J; Song Y; Peng J; Zhang S; Du Q; Chen Y
J Adv Res; 2024 May; ():. PubMed ID: 38768811
[TBL] [Abstract][Full Text] [Related]
16. CST6 protein and peptides inhibit breast cancer bone metastasis by suppressing CTSB activity and osteoclastogenesis.
Li X; Liang Y; Lian C; Peng F; Xiao Y; He Y; Ma C; Wang Y; Zhang P; Deng Y; Su Y; Luo C; Kong X; Yang Q; Liu T; Hu G
Theranostics; 2021; 11(20):9821-9832. PubMed ID: 34815788
[No Abstract] [Full Text] [Related]
17. Research on the efficacy of Celastrus Orbiculatus in suppressing TGF-β1-induced epithelial-mesenchymal transition by inhibiting HSP27 and TNF-α-induced NF-κ B/Snail signaling pathway in human gastric adenocarcinoma.
Zhu Y; Liu Y; Qian Y; Dai X; Yang L; Chen J; Guo S; Hisamitsu T
BMC Complement Altern Med; 2014 Nov; 14():433. PubMed ID: 25370696
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of miR-210 induced by a hypoxic microenvironment promotes breast cancer stem cells metastasis, proliferation, and self-renewal by targeting E-cadherin.
Tang T; Yang Z; Zhu Q; Wu Y; Sun K; Alahdal M; Zhang Y; Xing Y; Shen Y; Xia T; Xi T; Pan Y; Jin L
FASEB J; 2018 Sep; ():fj201801013R. PubMed ID: 30188754
[TBL] [Abstract][Full Text] [Related]
19. Actinidia chinensis Planch prevents proliferation and migration of gastric cancer associated with apoptosis, ferroptosis activation and mesenchymal phenotype suppression.
Gao Z; Deng G; Li Y; Huang H; Sun X; Shi H; Yao X; Gao L; Ju Y; Luo M
Biomed Pharmacother; 2020 Jun; 126():110092. PubMed ID: 32203890
[TBL] [Abstract][Full Text] [Related]
20. Enhancing anti-tumor potential: low-intensity vibration suppresses osteosarcoma progression and augments MSCs' tumor-suppressive abilities.
Xiong X; Huo Q; Li K; Cui C; Chang C; Park C; Ku B; Hong CS; Lim H; Pandya PH; Saadatzadeh MR; Bijangi-Vishehsaraei K; Lin CC; Kacena MA; Pollok KE; Chen A; Liu J; Thompson WR; Li XL; Li BY; Yokota H
Theranostics; 2024; 14(4):1430-1449. PubMed ID: 38389836
[No Abstract] [Full Text] [Related]
[Next] [New Search]
